|MDACC Study No:||COGAALL0932 (clinicaltrials.gov NCT No: NCT01190930)|
|Title:||AALL0932, Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or localized B-Lineage Lymphoblastic Lymphoma (B-LLy)|
|Principal Investigator:||Cesar Nunez|
|Treatment Agent:||6-mercaptopurine; Cyclophosphamide; Cytarabine; Dexamethasone; Methotrexate; Pegasparagase; Vincristine|
|Study Description:||The goal of this part of the clinical research study is to collect information |
about the quality of life of children with AR B-ALL.
This study is called a clinical trial. A clinical trial is a research study
involving treatment of a disease in human patients. This study is organized by
Children's Oncology Group (COG). COG is an international research group that
conducts clinical trials for children with cancer. More than 200 hospitals in
North America, New Zealand and Europe are members of COG.